Cargando…
Monitoring a high-cost drug in critical care units
Autores principales: | Yassin, S, Wells, H, Batra, R, McKenzie, C, Wyncoll, D, Offord, R, McLuckie, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092764/ http://dx.doi.org/10.1186/cc4736 |
Ejemplares similares
-
Outcomes and incidence of bleeding events associated with drotrecogin alfa: a single-centre experience of 440 patients
por: Boyle, A, et al.
Publicado: (2010) -
Levosimendan: experience of an adult ICU
por: Lippett, S, et al.
Publicado: (2006) -
Prevalence of Gram-negative bacilli resistance in adult critically ill patients at admission screening
por: Kotwinski, D, et al.
Publicado: (2011) -
Allergy documentation and transfer within critical care
por: Hatton, K, et al.
Publicado: (2010) -
Peaks and troughs: variations in the availability of therapeutic drug monitoring in critical care units across London
por: Grailey, KE, et al.
Publicado: (2015)